CA2501760A1 - Nasally applicable pharmaceutical preparation and the production thereof - Google Patents

Nasally applicable pharmaceutical preparation and the production thereof Download PDF

Info

Publication number
CA2501760A1
CA2501760A1 CA002501760A CA2501760A CA2501760A1 CA 2501760 A1 CA2501760 A1 CA 2501760A1 CA 002501760 A CA002501760 A CA 002501760A CA 2501760 A CA2501760 A CA 2501760A CA 2501760 A1 CA2501760 A1 CA 2501760A1
Authority
CA
Canada
Prior art keywords
buffer
malic acid
preparation
pharmaceutical preparation
employed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002501760A
Other languages
English (en)
French (fr)
Inventor
Ernst Hesse
Gerhard Hantich
Wolfgang H. Nitschmann
Helmut Scheidl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gebro Pharma GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2501760A1 publication Critical patent/CA2501760A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002501760A 2002-10-10 2003-10-09 Nasally applicable pharmaceutical preparation and the production thereof Abandoned CA2501760A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ATA1540/2002 2002-10-10
AT0154002A AT413078B (de) 2002-10-10 2002-10-10 Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
PCT/AT2003/000306 WO2004032896A1 (de) 2002-10-10 2003-10-09 Nasal applizierbare pharmazeutische zubereitung und deren herstellung

Publications (1)

Publication Number Publication Date
CA2501760A1 true CA2501760A1 (en) 2004-04-22

Family

ID=32074994

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002501760A Abandoned CA2501760A1 (en) 2002-10-10 2003-10-09 Nasally applicable pharmaceutical preparation and the production thereof

Country Status (9)

Country Link
US (1) US20060127317A1 (enExample)
EP (1) EP1549288A1 (enExample)
JP (1) JP2006503868A (enExample)
AT (1) AT413078B (enExample)
AU (1) AU2003266811A1 (enExample)
CA (1) CA2501760A1 (enExample)
NO (1) NO20052251L (enExample)
PL (1) PL375762A1 (enExample)
WO (1) WO2004032896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
WO2015054429A1 (en) * 2013-10-08 2015-04-16 Innopharma, Inc Aprepitant oral liquid formulations
WO2018112061A1 (en) 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

Also Published As

Publication number Publication date
JP2006503868A (ja) 2006-02-02
AU2003266811A1 (en) 2004-05-04
PL375762A1 (en) 2005-12-12
NO20052251L (no) 2005-05-09
US20060127317A1 (en) 2006-06-15
ATA15402002A (de) 2005-04-15
AT413078B (de) 2005-11-15
WO2004032896A1 (de) 2004-04-22
EP1549288A1 (de) 2005-07-06

Similar Documents

Publication Publication Date Title
EP0197718B2 (en) New medicaments for topical use
US20190240337A1 (en) Epinephrine formulations for medicinal products
HU207950B (en) Process for producing pharmaceutical eye-drop composition
CN1126535C (zh) 鼻内给药的水悬浮液
US5688532A (en) Antiallergic spray preparations
JPS6036414A (ja) 口鼻咽粘膜用医薬
CN102159244A (zh) 包含减充血剂和皮质类固醇的鼻内组合物
CA2159288A1 (en) Aqueous nasal suspension
EP1004307B1 (en) Ophthalmic composition
DE112019000683T5 (de) Intranasale epinephrin-formulierungen und verfahren zur behandlung von erkrankungen
EP0240907B1 (de) Verwendung von trans-4-[(2-Amino-3,5-dibrom-benzyl)-amino]cyclohexanol
CA2501760A1 (en) Nasally applicable pharmaceutical preparation and the production thereof
JPH02196716A (ja) 薬学的溶液
WO2003011249A2 (en) Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome
EP3664818B1 (en) Nasal decongestant compositions comprising menthol, dexpanthenol and sodium hyaluronate
ZA200502883B (en) Nasally applicable pharmaceutical preparation and the production thereof
JP2000109425A (ja) 花粉破裂防止剤、花粉破裂防止方法及び粘膜用洗浄剤
RU2496477C1 (ru) Раствор ипратропия бромида
WO2008098122A2 (en) Method for treating allergic rhinitis without adverse effects
JPH08151332A (ja) 点鼻用水性懸濁液
TW304879B (enExample)
JPS63502270A (ja) 散瞳作用を有する眼科用医薬組成物
RU2662099C1 (ru) Фармацевтические композиции для ингаляций, содержащие нитропростон
US20020151562A1 (en) Compositions and methods for treating allergic fungal sinusitis
JP2002338461A (ja) 鼻疾患治療薬

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued